Luca Ruffini

Luca Ruffini is a seasoned professional in the pharmaceutical industry, currently serving as the General Manager for the Italian affiliate of Amarin Corporation since July 2022, where the focus is on leading innovative cardiovascular disease management products. Prior to joining Amarin, Luca held various leadership positions at Amgen from October 2017 to June 2022, overseeing multiple business units including chronic disease and general medicine, and leading the European cardiovascular marketing team. Luca's extensive experience also includes significant roles at Pfizer from May 2003 to October 2017, such as Head of Marketing for the Oncology Business Unit in Italy and Country Brand Leader for Lipitor, the world's best-selling medication. Earlier career experience includes product management at GSK. Luca holds a degree in Pharmacy from Sapienza Università di Roma and has furthered education at ESCP Business School and SDA Bocconi.